Interleukin-4 and melatonin ameliorate high glucose and interleukin-1β stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells

Molecular Vision

Volumn 20, Issue , 2014, Pages 921-928

  Xie, Manyun ^a   Hu, Andina ^a   Luo, Yan ^a   Sun, Wei ^a   Hu, Xinqian ^a   Tang, Shibo ^b,c,d  

^a SUN YAT SEN UNIVERSITY   (China)

^b Aier Eye Hospital Group   (China)

^c Changsha Aier Eye Hospital   (China)

^d Aier Research Institute of Ophthalmology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MELATONIN; MESSENGER RNA; RECOMBINANT INTERLEUKIN 4; VASCULOTROPIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA CELL; RETINA NEOVASCULARIZATION; RETINAL ENDOTHELIAL CELL; RETINAL PIGMENT EPITHELIAL CELL; UPREGULATION;

DIABETES MELLITUS; DOWN-REGULATION; ENDOTHELIAL CELLS; EPITHELIAL CELLS; GLUCOSE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; INTERLEUKIN-4; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELATONIN; RETINAL PIGMENT EPITHELIUM; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84903898156     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010; 376: 124-36. [PMID: 20580421].
2. Hopps E, Canino B, Caimi G. Effects of exercise on inflammation markers in type 2 diabetic subjects. Acta Diabetol 2011; 48: 183-9. [PMID: 21431832].
3. Hong KH, Cho ML, Min SY, Shin YJ, Yoo SA, Choi JJ, Kim WU, Song SW, Cho CS. Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Clin Exp Immunol 2007; 147: 573-9. [PMID: 17302909].
4. Andina Hu. Study of the associated factors of the presence of proliferative diabetic retinopathy in type 2 diabetic patients. Doctor thesis: Zhongshan Ophthalmic Center, Sun Yat-Sen University; 2011.
5. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200. [PMID: 16217132].
6. Shaji AV, Kulkarni SK, Agrewala JN. Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin-specific T cells. Clin Exp Immunol 1998; 111: 181-5. [PMID: 9472679].
7. Maestroni GJ, Conti A, Lissoni P. Colony-stimulatingactivityand hematopoietic rescue from cancerchemotherapycompoundsareinducedbymelatoninviaendogenousinterleukin4. Cancer Res 1994; 54: 4740-3. [PMID: 7914829].
8. Sha S, Xing XN, Guo WS, Li Y, Zong LX, Guo R, Cao YP. In vivo electroporation of a new gene vaccine encoding ten repeats of Aβ3-10 prevents brain Aβ deposition and delays cognitive impairment in young Tg-APPswe/PSEN1dE9 mice. Neurochem Res 2012; 37: 1534-44. [PMID: 22437434].
9. Liu Y, Biarnés Costa M, Gerhardinger C. IL-1beta is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1beta autostimulation. PLoS ONE 2012; 7: e36949-[PMID: 22615852].
10. Xie L, Zhu X, Hu Y, Li T, Gao Y, Shi Y, Tang S. Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs. Invest Ophthalmol Vis Sci 2008; 49: 4203-9. [PMID: 18539942].
11. Yue BY, Kawa JE, Chang IL, Sawaguchi S, Fishman GA. Effects of chondroitin sulfate on cultured human retinal pigment epithelial cells. Cell Biol Int Rep 1991; 15: 365-76. [PMID: 1913846].
12. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18: 1450-2. [PMID: 15231732].
13. Meleth AD, Agrón E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL 3rd, Chew EY. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46: 4295-301. [PMID: 16249511].
14. Steinle JJ. Sympathetic neurotransmission modulates expression of inflammatory markers in the rat retina. Exp Eye Res 2007; 84: 118-25. [PMID: 17067575].
15. Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA. Vitreousandaqueousconcentrations of proangiogenic, antiangiogenic factors and othercytokinesindiabetic retinopathypatientswith macular edema: Implications for structural differences in macular profiles. Exp Eye Res 2006; 82: 798-806. [PMID: 16324700].
16. Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, Hori S. Aqueous humorlevels ofcytokinesare related tovitreouslevels and progression ofdiabetic retinopathyindiabeticpatients. Graefes Arch Clin Exp Ophthalmol 2005; 243: 3-8. [PMID: 15258777].
17. Adamiec-Mroczek J, Oficjalska-Młyńczak J, Misiuk-Hojło M. Proliferativediabetic retinopathy-The influence of diabetes control on the activation of the intraocular molecule system. Diabetes Res Clin Pract 2009; 84: 46-50. [PMID: 19237221].
18. Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferativediabetic retinopathy. Invest Ophthalmol Vis Sci 2003; 44: 2163-70. [PMID: 12714657].
19. Abu El-Asrar AM, Mohammad G, Nawaz MI, Siddiquei MM, Van den Eynde K, Mousa A, De Hertogh G, Opdenakker G. Relationship between vitreous levels of matrix metalloproteinases and vascular endothelialgrowth factor in proliferative diabetic retinopathy. PLoS ONE 2013; 8: e85857-[PMID: 24392031].
20. Joussen AM, Huang S, Poulaki V, Camphausen K, Beecken WD, Kirchhof B, Adamis AP. In vivo retinal gene expression in early diabetes. Invest Ophthalmol Vis Sci 2001; 42: 3047-57. [PMID: 11687554].
21. Tang J, Kern TS. Inflammation in Diabetic Retinopathy. Prog Retin Eye Res 2011; 30: 343-58. [PMID: 21635964].
22. Talahalli R, Zarini S, Sheibani N, Murphy RC, Gubitosi-Klug RA. Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci 2010; 51: 1699-708. [PMID: 19834040].
23. Kowluru RA, Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 2004; 88: 1343-7. [PMID: 15377563].
24. Bharadwaj AS, Appukuttan B, Wilmarth PA, Pan Y, Stempel AJ, Chipps TJ, Benedetti EE, Zamora DO, Choi D, David LL, Smith JR. Role of the retinal vascular endothelial cell in ocular disease. Prog Retin Eye Res 2013; 32: 102-80. [PMID: 22982179].
25. Simó R, Villarroel M, Corraliza L, Hernández C, Garcia-Ramírez M. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010; 2010: 190724-[PMID: 20182540].
26. Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 2003; 44: 2155-62. [PMID: 12714656].
27. Hua S. Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies. Front Pharmacol 2013; 4: 127-[PMID: 24109453].
28. El-Asrar AM. Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr J Ophthalmol 2012; 19: 70-4. [PMID: 22346117].
29. Bhatt LK, Addepalli V. Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats. Am J Transl Res 2010; 2: 181-9. [PMID: 20407607].
30. Alexander JS, Elrod JW. Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J Anat 2002; 200: 561-74. [PMID: 12162724].
31. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001; 21: 1104-17. [PMID: 11451738].
32. Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2003; 44: 2163-70. [PMID: 12714657].
33. Salzmann J, Limb GA, Khaw PT, Gregor ZJ, Webster L, Chignell AH, Charteris DG. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 2000; 84: 1091-6. [PMID: 11004090].
34. De La Paz MA, Itoh Y, Toth CA, Nagase H. Matrix metalloproteinases and their inhibitors in human vitreous. Invest Ophthalmol Vis Sci 1998; 39: 1256-60. [PMID: 9620087].
35. Collins FS, Green ED, Guttmacher AE, Guyer MS. US National Human Genome Research Institute. A vision for the future of genomics research. Nature 2003; 422: 835-47. [PMID: 12695777].
36. Choi P, Reiser H. IL-4: role in disease and regulation of production. Clin Exp Immunol 1998; 113: 317-9. [PMID: 9737656].
37. Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP. Inhibition of angiogenesis by interleukin 4. J Exp Med 1998; 188: 1039-46. [PMID: 9743522].
38. Adão-Novaes J, Guterres Cde C, da Silva AG, Campello-Costa P, Linden R, Sholl-Franco A. Interleukin-4 blocks thapsigargin-induced cell death in rat rod photoreceptors: involvement of cAMP/PKA pathway. J Neurosci Res 2009; 87: 2167-74. [PMID: 19235892].
39. Esposito E, Cuzzocrea S. Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 2010; 8: 228-42. [PMID: 21358973].
40. Tosini G, Baba K, Hwang CK, Iuvone PM. Melatonin: an underappreciated player in retinal physiology and pathophysiology. Exp Eye Res 2012; 103: 82-9. [PMID: 22960156].
41. Liang FQ, Green L, Wang C, Alssadi R, Godley BF. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res 2004; 78: 1069-75. [PMID: 15109913].
42. Liang FQ, Aleman TS. ZaixinYang, Cideciyan AV, Jacobson SG, Bennett J. Melatonin delays photoreceptor degeneration in the rds/rds mouse. Neuroreport 2001; 12: 1011-4. [PMID: 11303736].
43. Jiang T, Chang Q, Zhao Z, Yan S, Wang L, Cai J, Xu G. Melatonin-mediated cytoprotection against hyperglycemic injury in Müllercells. PLoS ONE 2012; 7: e50661-[PMID: 23226532].
44. Kaur C, Sivakumar V, Robinson R, Foulds WS, Luu CD, Ling EA. Neuroprotective effect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats. J Pineal Res 2013; 54: 190-206. [PMID: 23113620].